Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.41 |
| ▸ | APAF1 | O14727 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10028286 | 0.76 | MAPT (0.43) | ALDH1A1MAPTHPGDMAPK1KDM4E | |
| SCHEMBL276263 | 0.75 | HTR6 (0.40) | ALDH1A1MAPTHPGDKDM4ECYP3A4 | |
| SCHEMBL13851701 | 0.67 | PARP1 (0.40) | ALDH1A1MAPTHPGDMAPK1KDM4E | |
| SCHEMBL2566227 | 0.64 | CES1 (0.50) | ALDH1A1MAPTHPGDMAPK1KDM4E | |
| SCHEMBL476571 | 0.64 | HTR6 (0.36) | CYP3A4LMNAMCL1SMN1; SMN2BCL2 | |
| SCHEMBL4436441 | 0.62 | CES1 (0.43) | HPGDL3MBTL1NPC1RAB9AMAOA | |
| SCHEMBL1941287 | 0.62 | ALDH1A1 (0.40) | ALDH1A1MAPTHPGDMAPK1KDM4E | |
| SCHEMBL28347434 | 0.62 | ALDH1A1 (0.50) | ALDH1A1MAPTHPGDMAPK1KDM4E | |
| SCHEMBL29554575 | 0.60 | MEN1 (0.57) | ALDH1A1MAPTHPGDMAPK1KDM4E | |
| SCHEMBL342409 | 0.59 | KDM4E (1.00) | ALDH1A1MAPTHPGDMAPK1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113329993-A | Use of polyhydroxy aromatic compounds for treating fibrous substrates based on amino acids | 迈图高新材料有限责任公司 | 2021-08-31 | — | — | CN | claimed |
| US-20200163850-A1 | USE OF POLYHYDROXYAROMATIC COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID BASED SUBSTRATES | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2020-05-28 | — | — | US | claimed |
| US-20080058435-A1 | Halogen-Fere Flame-Retarded Polymer Foams | BASF AKTIENGESELLSCHAFT (DE) | 2008-03-06 | — | — | US | claimed |
| EP-1791896-B1 | HALOGEN-FREE FLAME-RETARDED POLYMER FOAMS | BASF AG (DE) | 2008-02-13 | — | — | EP | claimed |
| US-20080027023-A1 | Antiproliferative Compositions Comprising Aryl Substituted Xylopyranoside Derivatives | GLUCOGENE MEDICAL HFM AB (SE) | 2008-01-31 | — | — | US | claimed |
| EP-1765363-A2 | NEW COMPOSITIONS | GLUCOGENE MEDICAL HFM AB (SE) | 2007-03-28 | — | — | EP | claimed |
| WO-2006006933-A2 | ANTIPROLIFERATIVE COMPOSITIONS COMPRISING ARYL SUBSTITUTED XYLOPYRANOSIDE DERIVATIVES | GLUCOGENE MEDICAL HFM AB (SE) | 2006-01-19 | — | — | WO | claimed |
| JP-2003520819-A | — | — | 2003-07-08 | — | — | JP | claimed |
| US-20030092637-A1 | Novel compounds | XYLOGEN AB (SE) | 2003-05-15 | — | — | US | claimed |
| EP-1251859-A1 | NOVEL COMPOUNDS | Xylogen AB (SE) | 2002-10-30 | — | — | EP | claimed |
| WO-2001054702-A1 | NOVEL COMPOUNDS | XYLOGEN AB (SE) | 2001-08-02 | — | — | WO | claimed |
| CN-113329993-A | Use of polyhydroxy aromatic compounds for treating fibrous substrates based on amino acids | 迈图高新材料有限责任公司 | 2021-08-31 | — | — | CN | disclosed |
| US-20200163850-A1 | USE OF POLYHYDROXYAROMATIC COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID BASED SUBSTRATES | CITIBANK, N.A., AS ADMINISTRATIVE AGENT | 2020-05-28 | — | — | US | disclosed |
| US-7968591-B2 | 1,3-disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their use in medicaments | GRUENENTHAL GMBH (DE) | 2011-06-28 | — | — | US | disclosed |
| US-20090137573-A1 | 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their Use in Medicaments | GRUENENTHAL GMBH (DE) | 2009-05-28 | — | — | US | disclosed |
| EP-1791896-B1 | HALOGEN-FREE FLAME-RETARDED POLYMER FOAMS | BASF AG (DE) | 2008-02-13 | — | — | EP | disclosed |
| EP-1791896-A1 | HALOGEN-FREE FLAME-RETARDED POLYMER FOAMS | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-06 | — | — | EP | disclosed |
| WO-2006027241-A1 | HALOGEN-FREE FLAME-RETARDED POLYMER FOAMS | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-16 | — | — | WO | disclosed |
| US-20030092637-A1 | Novel compounds | XYLOGEN AB (SE) | 2003-05-15 | — | — | US | disclosed |
| US-4599397-A | MELT-MOLDABLE | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) | 1986-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030092637-A1 | Novel compounds | ENTPD5, G6PD, G6PC1 | ALDH1A1 986/4885MAPT 2389/4885HPGD 431/4885 |
| US-20090137573-A1 | 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their Use in Medicaments | OPRL1, TPH1, OPRK1 | ALDH1A1 2168/4885MAPT 1404/4885HPGD 936/4885 |
| US-20080027023-A1 | Antiproliferative Compositions Comprising Aryl Substituted Xylopyranoside Derivatives | UGGT1, B3GAT3, MKI67 | ALDH1A1 1972/4885MAPT 4677/4885HPGD 1109/4885 |
| US-20200163850-A1 | USE OF POLYHYDROXYAROMATIC COMPOUNDS FOR THE TREATMENT OF FIBROUS AMINO ACID BASED SUBSTRATES | PAH, CUTA, ASPH | ALDH1A1 867/4885MAPT 676/4885HPGD 700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.